ライフサイエンスコーパス: nude

1 ation requires LIS1 and its binding protein, NudE.

2 1/2 inhibitors in reversing vasoocclusion in nude and humanized SCD mouse models of acute vasoocclusi

3 r SK-MEL-05, tumor inhibition was similar in nude and Nod-Scid mice and was less efficient than seen

4 We also observe that T-cell-deficient (nude and Rag1-null mutant) pregnant mice do not exhibit

5 nsplanted BVE-PTC tumors subcutaneously into nude and TPO-Braf(WT) mice.

6 the transplanted tumors was observed in both nude and TPO-Braf(WT) mice.

7 of male and female mice (129S6/SvEv, athymic nude, and BALB/c).

8 d time-dependent tumor uptake was studied in nude BALB/c mice bearing a subcutaneous HER3 overexpress

9 p to 6 d after intravenous administration to nude BALB/c mice bearing high EpCAM-expressing HT-29 col

10 umor growth was significantly decreased when nude BALB/c mice were injected with Msi1-knockdown BCCs.

11 ains were evaluated: Swiss, BALB/c, C57BL/6, nude, beige, A/J, and GKO.

12 Astonishingly, the requirement for LIS1 or NudE can be bypassed to a significant extent by mutation

13 cells were implanted in the flank of athymic nude female mice.

14 In another mouse model using female NCr nude homozygous mice with U87 xenografts, tumor growth w

15 CD-1 nude immunodeficient mice were split into four experimen

16 was performed in tumour xenografts in 15 NCr nude immunodeficient mice, which were treated with eithe

17 r the cytoplasmic dynein regulators LIS1 and NudE/L (Nde1/Ndel1), but not for the dynactin p150(Glued

18 scles were subcutaneously injected into CD-1 nude mice (CD-1 nude mice, Crl:CD1-Foxn1(nu); Charles Ri

19 and prostate carcinoma xenograft lesions in nude mice (eight and five-fold respectively).

20 el) into groups of 4-week-old athymic female nude mice (induced with subcutaneous triple negative xen

21 cells from the rectus abdominis muscle into nude mice (n = 18).

22 in human T2D M2MPhis transplanted to athymic nude mice (NMRI-Foxn1(nu)/Foxn1(nu) ) or systemic inhibi

23 taxel-induced mechanical allodynia in female nude mice (T-cell and B-cell deficient).

24 Human NK cells injected in CD1 nude mice accumulated in the ARO tumors within 24 h and

25 cells, and in both eight-patient bloods and nude mice administered with the labeled CTCs in comparis

26 K1/2 inhibitor given to TNF-alpha-pretreated nude mice after human SSRBC infusion and onset of vasooc

27 experiments were performed on tumor-bearing nude mice after subcutaneous injection of RIN-m5F cells.

28 lanted into the peritoneal pouch of diabetic nude mice also reversed hyperglycemia successfully.

29 Xenografts in nude mice and bone metastasis models confirmed the remar

30 B or C-I inhibited tumor xenograft growth in nude mice and decreased the expression of CSC-markers an

31 ctively) to grow tumor xenografts in athymic nude mice and demonstrated the molecular specificity and

32 ed engrafting of pancreatic CSC's tumours in nude mice and displayed an antigrowth effect toward init

33 (67)Cu-CuSarTATE is well tolerated in BALB/c nude mice and highly efficacious against AR42J tumors in

34 evels of estradiol in human breast cancer in nude mice and in murine breast cancer in immune-competen

35 hibited cancer cell growth and metastasis in nude mice and inhibited cancer cell migration, invasion,

36 iments were then carried out in both healthy nude mice and nude mice with subcutaneous tumor to valid

37 s were grown as orthotopic tumors in athymic nude mice and PAF1 knockdown was induced by administrati

38 tifying the biodistribution of antibodies in nude mice and provides an alternative to PET analysis in

39 was initially established subcutaneously in nude mice and the subcutaneous tumor tissue was then ort

40 ChA-1 cells were injected into the flanks of nude mice and treated with miR-24 inhibitor or inhibitor

41 ly than Dox-MPEG-PCL and HK-MPEG-PCL in both nude mice and zebrafish tumor models.

42 Nude mice are an adequate model for in vivo chemotherapy

43 Nude mice are important in vivo model for characterizati

44 lantation of skin into SCID/beige or athymic nude mice at 2 independent sites.

45 We treated groups of nude mice bearing 7-d-old SW1222 xenografts with a fract

46 al PET experiments were performed in athymic nude mice bearing a BON-1 tumor xenograft.

47 FHNP and (18)F-FES were conducted in athymic nude mice bearing a SKOV3 xenografts.

48 these two dual-labeled conjugates in female nude mice bearing A2780 human ovarian carcinoma.

49 Irradiation of the nude mice bearing A431 xenograft tumors after intravenou

50 dent SSM3 mouse mammary tumors, male athymic nude mice bearing androgen-dependent CWR22 prostate canc

51 et involving ultrasound images of 23 athymic nude mice bearing C26 mouse adenocarcinomas was assemble

52 purified reagents were injected into athymic nude mice bearing CD44-positive human tumors (MDA-MB-231

53 get NCI-H358-HER2 CRISPR knock out tumors in nude mice bearing dual-flank tumor xenografts.

54 Athymic nude mice bearing EAC xenograft tumors (grown from OE-33

55 ncer xenografts, and male and female athymic nude mice bearing estrogen-independent MDA-MB-231 human

56 jected intravenously into the BALB/c athymic nude mice bearing folate receptor (FR)-overexpressing KB

57 EC2629 treatment of nude mice bearing FR-positive KB human xenografts led to

58 nd biodistribution studies were performed in nude mice bearing HCC4006 and A549 xenograft tumors.

59 s of intravenously injected nanoparticles in nude mice bearing HCT116 tumors radiosensitization was e

60 ance the anti-tumor activity of Sorafenib in nude mice bearing HepG2 xenografts.

61 rculation and evaluated the tumor binding in nude mice bearing heterotopic cervical (HT3), esophageal

62 icacy of PEG-GIRLRG peptide was evaluated in nude mice bearing heterotopic cervical (HT3), esophageal

63 antitumor efficacy over single treatment on nude mice bearing HT-29 colon cancer xenograft.

64 ed with [(68)Ga]Ga-FAPI-04 were conducted in nude mice bearing HT1080hFAP tumors or U87MG xenografts.

65 f biodistribution and PET imaging studies on nude mice bearing INR1G9-hGIPr tumors.

66 rubicin rapidly eradicated tumors in athymic nude mice bearing KB or MIA Paca-2 xenografts.

67 , small animal PET studies were conducted in nude mice bearing MCF-7-Y1 tumours.

68 and significantly improved survival time of nude mice bearing orthotopic GBM brain tumors.

69 In vivo antitumor efficacy was tested in nude mice bearing PSMA+ PC3 PIP or PSMA- PC3 flu flank x

70 tion and SPECT/CT imaging experiments, using nude mice bearing PSMA-positive PC-310 and PSMA-negative

71 macokinetics and PET imaging were studied in nude mice bearing rat Ins-1E tumors.

72 distribution experiments were performed with nude mice bearing RIN-m5F xenografts.

73 ected intravenously into separate cohorts of nude mice bearing subcutaneous A-431 tumors.

74 cer biodistribution was determined in BALB/c nude mice bearing subcutaneous CHL-GLP-1R xenografts.

75 of tumor cure while being well tolerated by nude mice bearing subcutaneous GPA33-positive SW1222 xen

76 One-hour dynamic PET scans were performed on nude mice bearing subcutaneous human head and neck tumor

77 Studies of nude mice bearing subcutaneous human HT-29 xenografts re

78 cs of (89)Zr-DFO-AC-10 was studied in BALB/c nude mice bearing subcutaneous human Karpas 299 tumors (

79 nts (0-72 h) was performed on female athymic nude mice bearing subcutaneous MKN-45 xenografts.

80 nd biodistribution studies were performed on nude mice bearing U87MG and MDA-MB-231 xenografted tumor

81 /kg MEK1/2 inhibitor to TNF-alpha-pretreated nude mice before human SSRBC infusion inhibited SSRBC ad

82 All experiments were conducted in athymic nude mice between October 2016 and March 2017.

83 o-CT was performed on HCC model implanted in nude mice by intrahepatic injection.

84 n HCC827, H1975, H358 and H520 tumor-bearing nude mice by PET/CT imaging.

85 in tumor xenografts grown in female athymic nude mice by small-animal PET/CT imaging and tissue biod

86 117085 significantly reduces tumor growth in nude mice compared with control untreated mice or either

87 Xenograft studies in NUDE mice demonstrated stable SOX2 repression and long-t

88 Importantly, nude mice developed anti-nuclear Abs when transplanted w

89 ASCT2ko 143B xenografts in nude mice exhibited a slower onset of growth and a highe

90 ntal pulp on poly-l-lactic acid scaffolds in nude mice gave rise to perfect heterotopic ossicles in v

91 V1-induced cSCC from back skin, into athymic nude mice gave rise to secondary cSCCs, which lacked vir

92 Nude mice implanted s.c. with TROP-2-expressing PC3 huma

93 growth of human colon carcinoma xenograft in nude mice in an RXRalpha-dependent manner.

94 of these mutant-expressing cells in athymic nude mice induced rapid tumor development, showing their

95 ties, SPECT and CT scans of HT29-xenografted nude mice injected with (177)Lu-3BP-227 were acquired, a

96 tically attenuates tumor growth in xenograft nude mice injected with human K562 leukemia cells and ce

97 Subcutaneous injection of TRIM24 iHMECs in nude mice led to growth of intermediate to high-grade tu

98 id gland scaffolds into the renal capsule of nude mice led to the differentiation of transplanted hDF

99 next evaluated in a validated orthotopic GBM nude mice model, studying the tumor growth over time by

100 potent anti-hepatoma activity in a xenograft nude mice model.

101 angiogenesis in chorioallantoic membrane and nude mice models.

102 0A silencing precluded liver colonization in nude mice or metastasis.

103 ast cancer were examined using female BALB/c nude mice orthotopically implanted with human breast car

104 implantation of LOX-treated neocartilage in nude mice promoted further maturation of the neotissue,

105 se model, after tumor establishment, athymic nude mice received treatment with progesterone or vehicl

106 Nude mice reconstituted with 10(5) T cells prior to chal

107 ansplantation of hERG1-expressing cells into nude mice resulted in an increased incidence of tumors.

108 5alpha-depleted pancreatic cancer cells into nude mice resulted in markedly reduced tumorigenicity (P

109 KD SCC1 cells into the floor of the mouth in nude mice resulted in the formation of significantly sma

110 human gliomas (U87) grown orthotopically in nude mice resulting in a more than a doubling of median

111 D25(+)IL7Ralpha(+)) after grafting recipient nude mice revealed that MPP3 cells were the most effecti

112 ografts of MKN45/5FU cells in the stomach of nude mice revealed that these cells had a high potential

113 nt lymphocytes in the demyelinated lesion of nude mice spinal cord.

114 pressed DNAJB6a formed tumors more slowly in nude mice than control cells or cells that expressed a m

115 ive MDA-MB-231 tumors to a greater extent in nude mice than in NSG mice, pointing to the potential ro

116 hen orthotopically implanted in the liver of nude mice to establish a PDOX model.

117 hyme were grafted under the renal capsule of nude mice to generate prostatelike tissues, and mice wer

118 s computed from ultrasound images of athymic nude mice to predict tumor response to treatment at an e

119 Diabetic athymic nude mice transplanted with 1500 to 3000 islet equivalen

120 Finally, PC3 xenograft nude mice treated with NLS in vivo showed a significant

121 A xenograft study in nude mice using 10 mg/kg of 5a had no effect on mice wei

122 ry cholangiocarcinoma (CCA) models in BALB/c nude mice using minimally invasive ultrasound-guided int

123 ia conditions, were then assessed in healthy nude mice using the left kidney and spleen as reference

124 he tracer in the pancreatic islets of BALB/c nude mice was examined using fluorescence microscopy.

125 of WT HBx-expressing cells to form tumors in nude mice was significantly higher than that of mutant H

126 transplantation of 100 transduced cells into nude mice was sufficient for tumor formation.

127 Methods: Female Foxn1(nu) athymic nude mice were administered 0, 50, or 600 kBq/kg (223)Ra

128 ard this end, orthotopic xenografts grown in nude mice were exposed to a fractionated radiation proto

129 Nude mice were given injections of genetically manipulat

130 Nude mice were given injections of Panc-1 cells, xenogra

131 Nude mice were given orthotopic injections of S2-007 cel

132 Nude mice were injected with breast cancer cells to moni

133 When nude mice were maintained on a diet lacking geranylgeran

134 1-CCK2R/A431-mock xenografted athymic BALB/c nude mice were used for biodistribution studies and smal

135 OIS and enabled tumor transplants to grow in nude mice with characteristic cell morphology of anaplas

136 In vivo treatment of A375 xenograft-bearing nude mice with cryptolepine (10 mg/Kg body weight, i.p.)

137 t overexpress MFSD2A were transferred to CD1 nude mice with dextran sodium sulfate-induced colitis, w

138 -octreotate treatment were studied in BALB/c nude mice with GOT1 tumors.

139 of (177)Lu-octreotate was examined in BALB/c nude mice with GOT2 tumors 1-168 h after injection with

140 tumor progression for SK-MEL-147 when using nude mice with no evidence of hepatotoxicity.

141 Pretreatment of nude mice with oral ginsenoside Ro followed by HT29 intr

142 Nude mice with orthotopic pancreatic tumors were randoml

143 ribution, and fluorescence imaging on BALB/c nude mice with orthotopically transplanted PC346C tumors

144 26 nmol/mouse, 8-9 MBq/mouse) in male BALB/c nude mice with PSMA-expressing subcutaneous LS174T-PSMA

145 In vitro and in vivo studies (nude mice with SKOV-3 xenografts) showed that (i) drug (

146 ing product, (18)F-FVIIai, was injected into nude mice with subcutaneous human pancreatic xenograft t

147 11B6 uptake was performed on NMRI and BALB/c nude mice with subcutaneous LNCaP xenografts up to 14 d

148 111)In-labeled ADCs were performed on BALB/c nude mice with subcutaneous PSMA-positive LS174T-PSMA xe

149 en carried out in both healthy nude mice and nude mice with subcutaneous tumor to validate the contra

150 Two groups of 6 adult female BALB/c nude mice with subcutaneously implanted tumors underwent

151 Methods: Two groups of 6 adult female BALB/c nude mice with subcutaneously implanted tumors underwent

152 Nude mice with xenograft tumors grown from HCT116, SNU-6

153 ot R-lycosin-I inhibited tumor growth in the nude mice xenograft model without generating side effect

154 ble for small-animal PET studies in multiple nude mice xenografted with the A431 carcinoma cell line.

155 Nude mice xenografted with the human NET cell line GOT1

156 Nude mice xenografts of HCC-70 or MDA-MB-468 were treate

157 nduced death in HT-29 and SW480 cells and in nude mice xenografts.

158 inhibition increased PC-3 tumor size in NCr nude mice xenografts.

159 ke (29-46% IA/g at 4 h in xenografted BALB/c nude mice).

160 ces hypoxia in FaDu and HCT116 xenografts in nude mice, and causes a significant tumour growth delay

161 lorectal cancer metastases were generated in nude mice, and epifluorescence imaging of ICG, as well a

162 y tumor sphere formation, tumor formation in nude mice, and expression of CSC markers.

163 ry tumorigenesis in tumor cell allografts in nude mice, and in MMTV-Neu transgenic mice.

164 matrix proteins, subcutaneous tumor size in nude mice, and invasive behavior, including bone marrow

165 nd cervical cancer cell xenograft in vivo in nude mice, and suppress cervical cancer cell migration a

166 nt growth inhibition of MOLM13 xenografts in nude mice, and the activity correlates with inhibition o

167 ulated into the left thyroid lobe of athymic nude mice, and the orthotopic tumor growth was monitored

168 2 were injected into the pancreas of athymic nude mice, and their local and distant spread was monito

169 ously and orthotopically implanted tumors in nude mice, and was accompanied by c-SRC downregulation.

170 mors and lung metastasis in immune-deficient nude mice, but not in immune-competent mice.

171 Within window chambers in nude mice, cardiopatches undergo vascularization by host

172 nhibited orthotopic prostate tumor growth in nude mice, compared with monotherapy, by reversing the e

173 In tumor-bearing Balb/c nude mice, conjugate 1 preferentially accumulates in the

174 taneously injected into CD-1 nude mice (CD-1 nude mice, Crl:CD1-Foxn1(nu); Charles River Laboratories

175 Importantly, when engrafted into nude mice, decitabine(R) and PKC412(R) had faster prolif

176 the OVCAR-3 and OVCAR-8 xenograft models in nude mice, demonstrating synergistic antitumor activity

177 cells were subcutaneously transplanted into nude mice, DPSC/CTL cells induced mineralized tissue for

178 man breast cancer (MCF-7 xenograft) model in nude mice, EO-33 blocked 90% of tumor growth induced by

179 utside the primary tumor microenvironment in nude mice, exhibited signatures of immune evasion, incre

180 Moreover, in MDA-MB-231-bearing nude mice, H3L2 induced dysfunctional angiogenesis and t

181 uding HUVEC-mediated trophoblast invasion in nude mice, in vitro three-dimensional capillary tube for

182 rs and xenografts established in NOD-SCID or nude mice, low MCPIP1 levels correlated strongly with in

183 uman prostate xenograft model established in nude mice, RAD001 alone or in combination with docetaxel

184 decreased spontaneous metastasis to lungs in nude mice, respectively.

185 Despite previous passage on nude mice, the expression of epithelial, stromal and imm

186 expressing versican siRNA were injected into nude mice, the resulting tumors displayed significantly

187 n PMP tissue was i.p. grafted and grown into nude mice, then constituted into reliable and reproducib

188 and AGS, which do and do not form tumors in nude mice, to identify their genomic differences relevan

189 an ovarian SKOV3 tumors cells into 14 female nude mice, treatment with vehicle or pazopanib (2.5 mg p

190 e than WT cybrids, however, when injected in nude mice, tRNAmut cybrids produced larger tumours and s

191 on in PCa cells and induces larger tumors in nude mice, whereas its silencing decreased proliferation

192 g in aggressive tumor formation in xenograft nude mice, which could be suppressed by combined treatme

193 Chronic treatment of nude mice, which had been inoculated with MDA-MB-231 cel

194 ive in suppressing xenograft tumor growth in nude mice, which underlines the translational potential

195 ous cell carcinoma upon inoculation into the nude mice, while parental HaCaT cells remain non-tumorig

196 G12C)-expressing human PDAC line, in athymic nude mice.

197 nvasion, migration, and xenograft tumors, in nude mice.

198 lation, Ki-67 expression and tumor growth in nude mice.

199 istant human ovarian cancer cells in athymic nude mice.

200 ess differentiated tumors when injected into nude mice.

201 nd diminishes tumorigenesis of xenografts in nude mice.

202 proliferation, migration and tumor growth in nude mice.

203 rived xenografts expressing SLC13A5-shRNA in nude mice.

204 -amplified neuroblastoma xenograft growth in nude mice.

205 ilage plugs were implanted subcutaneously in nude mice.

206 KB-3-1 and COLO-205 tumor xenograft-bearing nude mice.

207 xenografts in the mammary fat pads of female nude mice.

208 heroid formation and tumorigenesis in Balb/c nude mice.

209 s determined by xenograft studies in athymic nude mice.

210 to be nearly abolished in immunocompromised nude mice.

211 llomavirus has shown broad tissue tropism in nude mice.

212 CSC-like cells formed subcutaneous tumors in nude mice.

213 nd promotes the formation of fibrosarcoma in nude mice.

214 on and peritoneal tumor formation in athymic nude mice.

215 cells (A2780) implanted orthotopically into nude mice.

216 s ATF4 expression and its tumor formation on nude mice.

217 HV (TIVE-KSHV) into hyperglycemic and normal nude mice.

218 ly into NTR1-positive HT29 xenograft-bearing nude mice.

219 anted into calvarial defects created in CD-1 nude mice.

220 inhibition of HCC xenograft tumor growth in nude mice.

221 ctionally less effective at wound closure in nude mice.

222 l migration and abolished lung metastasis in nude mice.

223 bits proteasome function and tumor growth in nude mice.

224 cycle analysis and in vivo tumorigenesis in nude mice.

225 -expressing human lung cancer cell line into nude mice.

226 he multidrug resistant MCF-7/ADR xenografted nude mice.

227 plates, colonies in soft agar, and tumors in nude mice.

228 ses tumor growth and metastatic potential in nude mice.

229 rived orthotopic xenograft tumors in athymic nude mice.

230 ts and increases the median survival time of nude mice.

231 ancer cell proliferation and tumor growth in nude mice.

232 dard in vivo ectopic osteoinduction assay in nude mice.

233 on and a matrigel plug angiogenesis assay in nude mice.

234 om MDA-MB-231 BC cells in bones and lungs of nude mice.

235 blot assays, or injected subcutaneously into nude mice.

236 bited their tumorigenicity when engrafted in nude mice.

237 Calif) and injected in both flanks of eight nude mice.

238 a A375 human melanoma tumor model in athymic nude mice.

239 ion of breast cancer cell line xenografts in nude mice.

240 tocin-induced 8- to 10-week-old male athymic nude mice.

241 doses of a (90)Y-labeled GRPr antagonist in nude mice.

242 d into the distal posterior rectum of BALB/c-nude mice.

243 cell line and in vivo in PC-3 tumor-bearing nude mice.

244 nospheres in soft agar and nodules/tumors in nude mice.

245 gnificantly suppressed by NOS2 inhibition in nude mice.

246 in culture and promotes xenograft growth in nude mice.

247 duced tumorigenesis in an allograft model of nude mice.

248 ther subcutaneously or intraperitoneally, in nude mice.

249 ells in vitro and induces tumor formation in nude mice.

250 tion with the capacity to form metastases in nude mice.

251 orsphere assays and were less tumorigenic in nude mice.

252 sitive neovasculature when transplanted into nude mice.

253 -231 cells) growing in the brains of athymic nude mice.

254 m planar hair-bearing skin when grafted onto nude mice.

255 e diabetes after transplantation in diabetic nude mice.

256 ration, and/or growth of xenograft tumors in nude mice.

257 2Lp53-expressing cells were xenografted into nude mice.

258 idated in intracranial glioma bearing BALB/c nude mice.

259 vitro and growth of MDA-MB-468 xenografts in nude mice.

260 on CRPC cells in culture and implanted into nude mice.

261 uced the growth of human tumor xenografts in nude mice.

262 and a lung cancer tumor xenograft (A549) in nude mice.

263 etastases in human pancreatic cancer-bearing nude mice.

264 ggressive orthotopic tumor models in athymic nude mice: a human PC-3 M-luc-C6 prostate tumor and a hu

265 Nude mouse bioassay demonstrated better islet function f

266 through the layers and structures of ex vivo nude mouse ear skin and extracted pharmacokinetic parame

267 atient with DLL and propagated it in athymic nude mouse footpads.

268 patient-derived orthotopic xenograft (PDOX) nude mouse model of a highly aggressive liver metastasis

269 nsional culture and in an in vivo orthotopic nude mouse model of HNSCC through a novel transcription-

270 Using a xenograft nude mouse model of human glioblastoma multiforme, block

271 l lines and a spleen subcapsular inoculation nude mouse model were also used.

272 In the NMRI nude mouse model, we observed up to a 4.5-fold increase

273 elayed MPNST formation in an MPNST xenograft nude mouse model.

274 TUD5 knockdown accelerates tumor growth in a nude mouse model.

275 cancer cells in 4T1.2 BALB/cJ and MDA-MB-231 nude mouse models.

276 All athymic nude mouse strains showed active infections at both cuta

277 y, these in vitro results were replicated in nude mouse transplanted tumor models.

278 ion and a marked decrease in tumor growth in nude mouse xenograft assays.

279 regulation on tumor growth was analyzed in a nude mouse xenograft model.

280 itory activity against human glioblastoma in nude mouse xenograft models.

281 Growth suppression of nude mouse xenograft tumors carrying a tetracycline-indu

282 nesis upon subcutaneous transplantation in a nude mouse.

283 ) gene showed exon skipping at exon 7, while nudE neurodevelopment protein 1 (NDE1) gene showed repla

284 resent study, we generated a novel strain of nude NOD/SCID/IL2rg(-/-) (NSIN) mice by knocking out Fox

285 nd explored their biodistribution in athymic nude, NSG, and humanized NSG mice bearing human epiderma

286 was studied in normal and immune-deficient (nude, nu/nu) BALB/c mice infected with vaccinia virus (V

287 t but not in immunodeficient (IFNgamma(-/-), nude, or CD8(-/-)) mice.

288 tations in humans and mice give rise to the "nude" phenotype, which is marked by athymia.

289 ymic developmental defects and the hairless (nude) phenotype.

290 premalignancy and (b) an in vivo orthotopic nude rat lung cancer model to evaluate response to epige

291 efficacy of the DOT1L inhibitor EPZ5676 in a nude rat xenograft model of DNMT3A-mutant AML.

292 Nude rats bearing orthotopic U87 glioblastoma and health

293 or 13 d and then implanted subcutaneously in nude rats for 4 and 8 wk.

294 eck and 10 HT29 colorectal carcinoma-bearing nude rats were studied.

295 Male nude rats were subcutaneously inoculated in the shoulder

296 To study this, we inoculated 30 nude rats with HER2-positive cells derived from a brain

297 bcutaneous cancer esophageal xenografts, and nude rats with orthotopic esophageal cancers in four stu

298 al hair and nails, distinct from the classic nude/SCID phenotype in individuals with autosomal-recess

299 cell immune system since it did not occur in nude, severe combined immunodeficiency, or T-cell deplet

300 ecia, and nail dystrophy, accounting for the nude/severe combined immunodeficiency (nu/SCID) phenotyp